[Regulatory mechanism and potential value of circular RNA in nonalcoholic fatty liver disease progression].

作者：Qiuli Xie, L L Wang, Li Wang, Dongwei Yao, Min Yao · 发表于：PubMed · 年份：2022 · DOI：10.3760/cma.j.cn501113-20220827-00444 · 研究领域：Liver Disease Diagnosis and Treatment、Circular RNAs in diseases、Cancer-related molecular mechanisms research

Nonalcoholic fatty liver disease (nonalcoholic fatty liver disease, NAFLD) or metabolic-associated fatty liver disease, has become the most common chronic liver disease worldwide. In recent years, the relationship between NAFLD and non-coding RNA (ncRNA) has attracted the attention of basic and clinical researchers. Circular RNA (circRNA) is a lipid metabolism-related non-coding RNA (ncRNA) that is highly conserved in eukaryotic cells and resembles but differs from linear ncRNAs at their 5'- and 3'-terminal ends. With tissue-specific and steady expression of endogenous ncRNA, miRNA binding sites are contained on closed and circular nucleoside chains, forming the circRNA-miR-mRNA axis or network with proteins, competing with endogenous RNA sponge-like mechanisms, playing a role in inhibiting or promoting the expression of related target genes, and participating in the progression of NAFLD. This paper reviews the circRNA regulatory mechanism, detection technology, and potential clinical value in NAFLD.